Recombinant Human PDE3B Protein，GST

Phosphodiesterase 3B (PDE3B) is an important enzyme that plays a crucial role in regulating cellular levels of cyclic AMP (cAMP) and cyclic GMP (cGMP), which are vital secondary messengers involved in various physiological processes, including lipid metabolism, insulin signaling, and cardiac function. Dysregulation of PDE3B activity has been implicated in various metabolic disorders, such as obesity, type 2 diabetes, and cardiovascular diseases. Consequently, PDE3B has emerged as a promising target for therapeutic interventions aimed at these conditions. Research efforts have focused on the recombinant production of PDE3B protein to enable detailed biochemical studies, structural characterization, and high-throughput screening of potential inhibitors. The ability to produce active PDE3B in a recombinant system allows scientists to investigate its enzymatic properties, elucidate the mechanisms of its regulation, and explore its interactions with other signaling molecules. Understanding the structure-function relationship of PDE3B through crystallography and other biophysical techniques could aid in the rational design of specific inhibitors, paving the way for novel treatments for diseases associated with altered cAMP/cGMP signaling pathways. The ongoing exploration of PDE3B as a therapeutic target underscores its relevance in drug development and highlights the importance of recombinant protein research in advancing our understanding of complex biochemical pathways.